Haemodialysis session: The perfect storm for vascular calcification  by Seras, Miguel & Martín de Francisco, Ángel Luis
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sult was slight alkalinisation of the blood at the end of the
ialysis session. This modest change in blood pH suggested
at this does not play a substantial role in vascular calciﬁ-
tion. This was especially likely to be the case as this slight
kalinisation of the blood was lost after several hours.
Finally, without taking into account the fact that bicarbon-
e is responsible for the slight alkalinisation of the blood
uring dialysis, bicarbonate also plays a determinant role in
e production of calcium crystals, including hydroxyapatite,
 one of our studies has shown.4
Although it is a conceptual matter, it should be known
at bicarbonate is responsible for the increase in the calci-
cation process, whether directly by causing calcium crystals
r indirectly by causing slight alkalinisation. Therefore, bicar-
onate should be replaced with another buffering molecule
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ear Editor:
e  appreciate the interest shown and comments made by
illa-Bellosta et al. with respect to our recent publication.1
First, we  agree that the dialysis bath should be personalised
 generally achieve neutral calcium balances. As González-
rra et al.2 effectively demonstrated in their article, theredialysis plasma calcium cut-off points that would allow
ne or another concentration of calcium in the dialysis bath to
e decided on seem to be around 0.96 mmol/l and 1.01 mmol/l
.75–9.15 mg/dl, respectively). However, the aim of our study
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as not to determine these cut-off points, but to analyse
anges in calcaemia with randomly assigned calcium baths,
d their relationship with phosphorus and bicarbonate, in
ursuit of a parallel with studies in vitro by Lomashvili et al.3
d De Solis et al.4 Hence patients were classiﬁed as hypo-
r normocalcaemic based on 1.16 mM,  the lower limit of nor-hemodiálisis: la tormenta perfecta para la calciﬁcación vascular.
 calcaemia in our sample, based on the bath used, we
bserved that the 1.25 mM calcium bath scarcely induced
ypercalcaemia (>1.3 mM), while all patients dialysed with the
5 mM bath completed the session with hypercalcaemia (all
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independently of predialysis plasma calcium). Therefore, w
understand that, while the 1.25 mM calcium bath could b
considered to be “standard”, some situations require highe
or lower concentrations in order to achieve balances that ar
as neutral as possible, as we  initially remarked.
Second, we  have little to add to the comments made abou
the calcium-phosphorus product and the role historicall
attributed to it in vascular calciﬁcation. As O’Neill said in hi
publication, this entrenched dogma represents a simplisti
interpretation with little scientiﬁc basis,5 since the key to thi
complex process lies in calcium more  than phosphorus — t
say nothing of the host of inductive and protective factors in
vascular calciﬁcation proposed in recent years.
Finally, the question of whether it is the induction of alka
laemia or the addition of bicarbonate that induces vascula
calciﬁcation in the patient in haemodialysis is difﬁcult t
answer. Indeed, when bicarbonate is infused, the increas
in pH is lower than expected. This may be explained on th
one hand by the isohydric principle (part of the bicarbonat
is consumed thereby restoring other plasma buffers, includ
ing phosphate, thereby generating precursors of brushit
and hydroxyapatite), and on the other hand by respirator
compensation.6 The fact is that, although the increase in pH
following a dialysis session might seem unimportant and even
transient, this should not lead to underestimating the exten
of underlying clinical-chemistry processes that are set in
motion to buffer the alkalaemia induced in such a short spac
of time, and that probably play a role in vascular calciﬁcation
associated with haemodialysis. In addition, as Villa-Bellost
et al. demonstrated in their article, bicarbonate in itself is abl
to form hydroxyapatite crystals when combined with infuse
calcium.7 Based on the above-mentioned studies in vitro,3,4 i
seems that the critical moment in which the addition of bicar
bonate would become more  harmful coincides with the ﬁrs
hour of a session, when calcium increases in the presence o
hyperphosphataemia. Although translating results in vitro t
daily clinical practice would be hasty and reductionist, thes
ﬁnding should incite reﬂection on the potential alternatives
Despite all this, the use of bicarbonate has manifest beneﬁt
in bone and protein metabolism that in its day represented an
advance with respect to acetate, which is now obsolete. Thi
leads to considering other ways of administering bicarbon
ate, for example by delaying its infusion during a session s
that it does not coincide with the adverse clinical-chemistr
scenario described above. Research on new bufferin 6(4):441–443 443
compounds would undoubtedly yield another opinion to be
considered.
In any case, vascular calciﬁcation is extremely complex
and it seems that various factors — active or passive, within
haemodialysis or outside of it — play one role or another in
the process.
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